Vinge advises Ellevio in connection with its acquisition of Markbygden Net AB, a modern transmission network which connects Europe’s largest wind farm cluster Markbygden 1101 outside Piteå in northern Sweden, from Svevind and Enercon.

Ellevio is one of Sweden’s biggest distribution network operators and, with the acquisition, Ellevio is establishing itself in Sweden’s northern electricity region for the first time, strengthening its role in accelerating Sweden’s journey towards net-zero emissions by 2045. Ellevio owns Markbygden Net AB as of 20 September 2023.

Vinge’s team consisted of partner in charge Peter Sundgren (Energy/M&A) together with Desirée Hagenfeldt, Robin Sultani and Eskil Nyström (M&A), Johan Cederblad and Madelene Andersson (Environment), Karolina Cohrs (Real estate), Mathilda Persson and Alva Skott (Commercial Agreements and IT), Mario Saad and Carl Lexenberg (Commercial Agreements), Daniel Wendelsson (Public procurement and FDI), Carl Johan af Petersens and Andrea Rökaas (Regulatory), Daniel Prawitz (Construction), Arvid Axelryd (IP), Amelia Rihs (Employment), David Flodin (Financial arrangements), Julia Löfqvist (Compliance) Gabriella Balbo and Jessica Henning (VDR).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025